Search the Newsreel

Boston Scientific Announces Major Restructuring, Job Cuts

Boston Scientific has approved a major restructuring plan to reduce annual costs by approximately $500 million by 2029. This initiative, which will cost between $700 million and $800 million and include job eliminations, is aimed at re-investing savings into strategic growth areas. The restructuring …

UBS lowers Boston Scientific stock price target on valuation reset

UBS has lowered its price target for Boston Scientific (NYSE:BSX) to $74 from $95 but maintained a Buy rating, citing that shares are near five-year lows without a structural change in business fundamentals. The firm believes the market has overly focused on key revenue …

BOSC: Backlog and global defense demand drive expectations to surpass 2025 revenue

BOSC is expected to surpass its 2025 revenue targets, primarily driven by strong defense demand, global expansion, and a robust backlog. Over 80% of its revenues are predictable, and the company maintains disciplined acquisition plans with improved margins despite currency pressures. This assessment is …

Boston Scientific earnings on deck as WATCHMAN slowdown looms

Boston Scientific is set to report second-quarter earnings with investors keenly focused on the performance of its WATCHMAN device, which has seen slowed sales, and the company's full-year guidance. Analysts expect modest EPS and revenue growth, but the stock has fallen significantly, and some …

Boston Scientific removes stroke prevention catheter after injury

Boston Scientific is removing certain catheters used for stroke prevention treatment due to a risk of the device tip separating during a procedure. The company has reported one injury related to this issue, which can lead to complications such as embolism, stroke, or the …

Boston Scientific Q2 2026 Earnings Preview

* Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) is scheduled to announce Q2 earnings results on Wednesday, July 29th, before market open. * The consensus EPS Estimate is $0.83 [https://seekingalpha.com/symbol/BSX/earnings/estimates] (+10.7% Y/Y) and the consensus revenue estimate is $5.37B (+6.1% Y/Y). * Over the last 2 years, …

Frasers’ Hugo Boss takeover offer becomes unconditional after EU clearance

Frasers Group said its voluntary public takeover offer for Hugo Boss is now unconditional after receiving merger control approval from the European Commission (EC). The UK retail group, which owns businesses that include House of Fraser, Sports Direct and Flannels, already holds slightly more …

Boston Scientific Restructures Operations, Plans Workforce Cuts

Boston Scientific has announced a global restructuring plan approved on July 21, aiming for sustained cost efficiencies and continued growth, which will include headcount reductions. The company anticipates spending $700-800 million in pre-tax charges related to these efforts, which also involve supply chain optimization, …

Boston Scientific target price cut at UBS but remains a buy

UBS has lowered its price target for Boston Scientific (BSX) but maintains a "buy" rating. The firm believes that despite recent stock underperformance, growth will be driven by established business segments and new product launches.

Canaccord mantém recomendação de compra para ações da Boston Scientific após reestruturação - Investing.com Brasil

Canaccord reiterates Boston Scientific stock rating after restructuring

Canaccord Genuity reiterated a Buy rating and a $70.00 price target for Boston Scientific (NYSE:BSX) after the company announced a global restructuring plan. This plan aims to optimize the supply chain, transfer production lines, and transform organizational structure, with an expected pre-tax expense reduction …

Bosideng Sets AGM to Approve Dividend and Renew Share Issuance Mandate

What To Expect From Boston Scientific’s (BSX) Q2 Earnings

What To Expect From Boston Scientific's (BSX) Q2 Earnings Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday morning. Here's what to expect. Boston Scientific beat analysts' revenue expectations last quarter, reporting revenues of $5.20 billion, up 11.6% year on year. …

Boston Scientific Corp (BSX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Boston Scientific Corp (BSX), stating its current valuation score is 8.09, ranking 109 out of 199 in its industry. The company's P/E ratio is 18.93, significantly below its recent high but slightly above its recent low. The …

Boston Scientific Restructuring To Trim Workforce

(RTTNews) - Boston Scientific Corp (BSX) has unveiled a sweeping global restructuring program, according to its Form 8-K filing with the U.S. Securities and Exchange Commission. The plan, approved by the board of directors, is designed to streamline operations, optimize supply chains, and align …

Is The Boston Beer Company (SAM) Stock a Buy as Margin Gains Offset Ongoing Volume Declines?

Bosideng (SEHK:3998) Stock Price Lags Profit Growth Despite Margin Gains

ETFs Investing in Boston Beer Company, Inc. Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Boston Beer Company, Inc. Class A (BBEA) stocks, providing crucial investment data for each. It details metrics such as market value, weight of BBEA in the fund, issuer, management style, expense ratio, AUM, price, …

Boston Scientific to restructure, cut costs by $500M annually

Boston Scientific Corp. is implementing a new 2026 Restructuring Plan to address challenges with key revenue drivers. This initiative is expected to lead to layoffs and aims to cut annual costs by $500 million. The company is responding to difficulties in its major financial …

Boston Scientific unveils new restructuring plan, expects job cuts

Boston Scientific's board has approved a new company-wide restructuring plan aimed at cutting costs and positioning the company for future growth. The plan, which involves supply chain optimization, production shifts, and organizational changes, is expected to result in some job losses while also involving …

Boston Scientific (NYSE: BSX) sets $700–$800 million restructuring with $500 million savings

Boston Scientific (NYSE: BSX) has approved a new global restructuring program, the 2026 Restructuring Plan, with estimated pre-tax charges of $700 million to $800 million. The plan aims to optimize the supply chain, transfer production lines, and reshape organizational structures to achieve sustained cost …

BOS Better Online Solutions Ltd (BOSC) Cash Flow

This article provides a detailed cash flow statement for BOS Better Online Solutions Ltd (BOSC), including quarterly data for operating, investing, and financing activities from Q1 2012 to Q4 2013. It also features a Q&A section explaining key concepts like operating cash flow, investing …

What's Going On With AirBoss of America Corp. Stock Monday?

Boston Scientific Overturns $42M Patent Verdict

The U.S. Court of Appeals for the Federal Circuit has overturned a $42 million patent verdict against Boston Scientific, ruling that the patent involving drug-eluting stents was invalid. This decision is expected to positively impact Boston Scientific's stock price and enhance its competitive position …

Bosideng International Holdings Limited Revenue Breakdown – HKEX:3998

Boston Scientific Gets $42 Million Stent Patent Verdict Reversed

The Federal Circuit has overturned a $42 million patent infringement verdict against Boston Scientific Corp. The ruling found that the patent held by the University of Texas related to medical devices, specifically drug-eluting stents, was invalid. A jury had previously determined Boston Scientific owed …

Boston Omaha Corporation (BOC) Edges Higher as Key Levels Hold - TPO Profile

BOS Better Online Solutions Ltd (BOSC) Shareholder Structure: Major Shareholders & Institutional Holdings

The article details the shareholder structure of BOS Better Online Solutions Ltd (BOSC), including a breakdown of major individual and institutional holders. It provides updated data on shareholder proportions by type and lists specific institutional holdings over several quarters, showing changes in shares held …

AirBoss of America (TSX:BOS) Rallies: Is a Long-Awaited Turnaround Finally Taking Hold?

What Boston Scientific (BSX)'s Stronger-Than-Expected Segment Earnings Mean For Shareholders

What To Expect From Boston Scientific's (BSX) Q2 Earnings Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday morning. Here's what to expect. Boston Scientific beat analysts' revenue expectations last quarter, reporting revenues of $5.20 billion, up 11.6% year on year. …

Minbos Resources Completes $2.61 Million Placement, Issues 174 Million Ordinary Shares

Boston Beer Faces Weak Demand While Margins and Innovation Diverge

Boston Scientific Corp (BSX) Cash Flow

This article provides detailed cash flow statements for Boston Scientific Corp (BSX), covering quarterly and annual operating, investing, and financing activities. It includes historical data dating back to FY2012Q1, along with year-over-year percentage changes. The article also features an FAQ section explaining key cash …

BOSC Balance Sheet - BOS Better Online Solutions Ltd

This article provides a detailed historical balance sheet for BOS Better Online Solutions Ltd (BOSC), offering quarterly data for various financial metrics such as cash, receivables, inventory, and total assets and liabilities. It also includes an FAQ section defining key balance sheet metrics and …

BSX|Boston Scientific Corp|Kurs:51.165|Änderung %:+0.705

Boston Beer Company, Inc. Class A Revenue Breakdown – MUN:BBEA

This article provides a revenue breakdown for Boston Beer Company, Inc. Class A (MUN:BBEA), highlighting that the Alcohol Beverages segment generated 1.67 billion EUR last year, down from 1.94 billion EUR the previous year. The United States was the largest contributor to revenue, accounting …